Status:
UNKNOWN
Efficacy of Pericapsular Nerve Group (PENG) Block for Hip Surgeries
Lead Sponsor:
Suez Canal University
Conditions:
Pain, Postoperative
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
To study the efficacy of the PENG block on the duration of postoperative analgesia. There are two groups of patients, who are undergoing hip joint surgeries, one group (Control Group) will receive spi...
Detailed Description
Research Question: Is PENG block effective in prolonging the duration of postoperative analgesia when compared to patients undergoing spinal anesthesia only? Research Hypothesis: PENG block is effe...
Eligibility Criteria
Inclusion
- Patients with hip fracture who will be subjected to surgical treatment
- ASA physical status 1, 2
Exclusion
- Patients with chronic pain before surgery (taking opioids).
- Patients with multiple trauma
- Patients who could not assess pain reliably (dementia).
- Substance abuse and prolonged intake of sedative drugs.
- Morbid obese patients (BMI\>35).
- Patients who have open wounds or infection at the site of the block.
Key Trial Info
Start Date :
June 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT06144931
Start Date
June 1 2023
End Date
March 1 2024
Last Update
November 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Suez Canal University
Ismailia, Egypt